CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$16.3M
Cap. Flow
+$8.43M
Cap. Flow %
6.73%
Top 10 Hldgs %
37.17%
Holding
71
New
8
Increased
24
Reduced
9
Closed
7
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
RIGL icon
Rigel Pharmaceuticals
RIGL
+$3.41M
2
TALO icon
Talos Energy
TALO
+$1.71M
3
CPA icon
Copa Holdings
CPA
+$1.58M
4
PK icon
Park Hotels & Resorts
PK
+$1.46M
5
FCX icon
Freeport-McMoran
FCX
+$1.35M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.59M
2
BABA icon
Alibaba
BABA
+$2.16M
3
NMRK icon
Newmark Group
NMRK
+$1.3M
4
RVNC icon
Revance Therapeutics, Inc.
RVNC
+$1.03M
5
HAS icon
Hasbro
HAS
+$878K

Sector Composition

Rank Sector Weight
1 Healthcare 39.93%
2 Materials 10.94%
3 Technology 9.96%
4 Industrials 9.07%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALCO icon
1
Alico
ALCO
$283M
$6.29M 5.02%
225,000
– –
2020 Q4
15 quarters
TGB
2
Trekor Metals
TGB
$3B
$6.17M 4.93%
2,450,000
– –
2020 Q4
15 quarters
RLGT icon
3
Radiant Logistics
RLGT
$423M
$4.98M 3.98%
775,000
– –
2020 Q4
15 quarters
FOLD icon
4
DELISTED
Amicus Therapeutics
FOLD
$4.81M 3.84%
450,000
– –
2020 Q4
15 quarters
RIGL icon
5
Rigel Pharmaceuticals
RIGL
$875M
$4.69M 3.74%
+290,000
New +$3.41M
2024 Q3
0 quarters
NMRK icon
6
Newmark Group
NMRK
$2.1B
$4.66M 3.72%
300,000
-100,000
-25% -$1.3M
2020 Q4
15 quarters
RPRX icon
7
Royalty Pharma
RPRX
$26.3B
$4.53M 3.61%
160,000
– –
2023 Q4
3 quarters
TALO icon
8
Talos Energy
TALO
$2.84B
$3.62M 2.89%
350,000
+150,000
+75% +$1.71M
2020 Q4
15 quarters
PLPC icon
9
Preformed Line Products
PLPC
$1.84B
$3.46M 2.76%
27,000
+1,000
+4% +$121K
2020 Q4
15 quarters
CLPT icon
10
ClearPoint Neuro
CLPT
$282M
$3.36M 2.68%
300,000
-75,000
-20% -$718K
2021 Q4
11 quarters
ARKO icon
11
ARKO Corp
ARKO
$453M
$3.26M 2.6%
1,020,000
– –
2021 Q1
14 quarters
KD icon
12
Kyndryl
KD
$2.57B
$3.22M 2.57%
140,000
– –
2021 Q4
11 quarters
PD icon
13
PagerDuty
PD
$1.31B
$2.78M 2.22%
150,000
+30,000
+25% +$585K
2023 Q2
5 quarters
INTT icon
14
inTEST
INTT
$168M
$2.56M 2.04%
350,000
+41,000
+13% +$340K
2023 Q4
3 quarters
BGC icon
15
BGC Group
BGC
$5.37B
$2.52M 2.01%
275,000
-50,000
-15% -$467K
2020 Q4
15 quarters
CGAU icon
16
Centerra Gold
CGAU
$4.12B
$2.51M 2%
350,000
+50,000
+17% +$344K
2023 Q4
3 quarters
B icon
17
Barrick Mining
B
$64B
$2.49M 1.98%
125,000
– –
2023 Q2
5 quarters
EOLS icon
18
Evolus
EOLS
$477M
$2.43M 1.94%
150,000
– –
2023 Q2
5 quarters
ARKR icon
19
Ark Restaurants
ARKR
$16.2M
$2.4M 1.91%
200,000
– –
2020 Q4
15 quarters
SABR icon
20
Sabre
SABR
$718M
$2.39M 1.9%
650,000
+50,000
+8% +$155K
2023 Q1
6 quarters
IOVA icon
21
Iovance Biotherapeutics
IOVA
$6.44B
$2.35M 1.87%
250,000
– –
2023 Q3
4 quarters
VTRS icon
22
Viatris
VTRS
$20B
$2.32M 1.85%
200,000
– –
2020 Q4
15 quarters
RBCAA icon
23
Republic Bancorp
RBCAA
$1.78B
$2.29M 1.82%
35,000
– –
2020 Q4
15 quarters
BRKL icon
24
DELISTED
Brookline Bancorp
BRKL
$2.27M 1.81%
225,000
+35,000
+18% +$344K
2022 Q4
7 quarters
JAZZ icon
25
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.23M 1.78%
20,000
+7,500
+60% +$822K
2024 Q1
2 quarters
1
2 3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q3 2024 Portfolio in Review

As of Q3 2024, CM Management held 71 positions worth $125M, up 15% from $109M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management deployed $8.43M of net new capital in Q3 2024, opening 8 new positions and adding to 24 existing holdings. Its largest new stake was Rigel Pharmaceuticals: 290,000 shares worth $4.69M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 36% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Newmark Group, an estimated $1.3M trimmed.

  • CM Management's largest Q3 2024 buy was Rigel Pharmaceuticals: 290,000 shares worth $4.69M.
  • CM Management added most to Talos Energy in Q3 2024, an estimated $1.71M increase.
  • CM Management's biggest Q3 2024 reduction was Newmark Group, cutting an estimated $1.3M.
  • CM Management fully exited Baidu in Q3 2024, selling an estimated $2.59M.
  • CM Management's ten largest holdings make up 37% of its $125M portfolio in Q3 2024.
  • CM Management opened 8 new positions and closed 7 in Q3 2024.
  • CM Management's portfolio value rose 15% quarter-over-quarter to $125M.

Based on CM Management's 13F filing for Q3 2024, filed 12 Nov 2024.